The main objective of Making Genetics is to identify, develop, implement in clinic and license new diagnostic and prognostic panels combining genetic and epigenetic biomarkers. For this we have the necessary experience for the analysis of the samples, for the bioinformatic studies that come from massive genomic and epigenomic analyzes, and for the biostatistical integration of biomarkers of different biological origins. The proposal of this segment is to become a company that develops personalized medicine by developing for its license a package of original biological determinations (combining different biomarkers) that can address the diagnosis of different diseases in a flexible way.


At the research and development level, we are working on the realization of a predictive algorithm for the severity of inflammatory and autoimmune diseases, based on genetic and epigenetic biomarkers, that allow us to market a service and / or license the technical procedure for its use in routine clinical practice. . Other R & D projects in which we are working are the development and commercialization of pediatric celiac biomarkers together with the Hospital of Navarra.

Meet our R&D


We offer companies and research groups analysis of genomic data (from NGS or microarray technology) through our Department of Bioinformatics together with the biological interpretation of the results. With the possibility of also performing laboratory analyzes.

Learn about our genomic services


At Making Genetics we offer a comprehensive genetic analysis service to companies that have their own commercial network. We offer these companies the development of on-demand genetic panels and the subsequent service during the marketing of custom genetic tests.

Meet our genetic testing service
Cecilia Galbete
Cecilia GalbeteCo-founder, CEO, CMO and
Doctor in Biological Sciences with more than 10 years of experience in scientific research (University of Navarra and German Institute of Human Nutrition) with a special focus on the field of Nutritional Epidemiology.
Adriana Moleres
Adriana MoleresCo-founder, CTO and R&D
PhD in Biological Sciences with mastery in several areas of knowledge such as Biochemical Genetics, Metabolic Processes, Human Genetics or Human Physiology with more than 7 years of experience in scientific research, has published in scientific journals such as Journal of Pediatrics, FASEB Journal and Pediatric Obesity.
Javier Campion
Javier CampionCo-founder, CSO and Scientific
PhD in Biological Sciences with mastery in several areas of knowledge such as Biochemistry, Molecular Biology and Human Genetics with more than 20 years of experience in scientific research (Complutense University, Karolinska Institute of Stockholm and University of Navarra) with more than 10 years of researcher responsible in projects related to nutrigenomics and epigenetics, has published in scientific journals such as Human Molecular Genetics, PLOSone and FASEB Journal.
Lorena Sánchez
Lorena SánchezQuality & Regulatory Director and Project Manager
PhD in Biology, Biochemistry and Molecular Biology Programme. Expertise in Inflammatory and autoimmune diseases and Quality and regulatory affairs of medical devices. Senior research experience focused on inflammatory diseases from areas like Immunology, Biochemistry, Cell Biology, Molecular Biology and Genomics. Carreer developed in Pharmacology and Toxicology Institute, the Complutense University of Madrid, Gregorio Marañón Hospital, the Center for Biological Research, Severo Ochoa Molecular Biology Centre and currently at Making Genetics. She has participated in translational research and technological transfer to pharmaceutical Industry such as PharmaMar. She has work for several years for the Spanish collaborative research network (RETICS) for inflammatory and rheumatic diseases.
María Luisa Mansego
María Luisa MansegoBioinformatics & IT Director
PhD in Molecular and Evolutionary Genetics with extensive experience in Population Genetics and Bioinformatics and more than 10 years of experience as a scientific researcher working in genotyping, epigenotyping and genetic diagnosis in the Research Center of the University Clinical Hospital of Valencia, the Príncipe Research Center Felipe and the University of Navarra.
Ainhoa Rípodas
Ainhoa RípodasR&D Administration and Accounting
Degree in Biological Sciences from the University of Navarra, Master in Biotechnology from the Complutense University of Madrid. Extensive experience in administration, accounting and R&D management in different companies.

This company has received aid from the expenditure budget of the Ministry of Economy and Competitiveness and co-financed by the European Regional Development Fund for the project RTC-2015-3562-1

This project has received funding from DIGI-B-CUBE voucher framework which has been supported by the European Union’s Horizon 2020 research and innovation programme under grant agreement No 824920.

This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement no. 877928.